Reaction
Gastrointestinal Microorganism Overgrowth reporting signals
As of the last recalculation, Gastrointestinal Microorganism Overgrowth appears in 306 FAERS reports alongside 9 co-occurring drug terms. The strongest observed disproportionality signal is TEDUGLUTIDE (PRR 193.0).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Teduglutide | 34 | 193.0 | 193.4 |
| Rifaximin | 48 | 184.7 | 185.1 |
| Pancrelipase | 27 | 52.1 | 52.1 |
| Lanreotide Acetate | 5 | 44.1 | 44.1 |
| Calcium, Magnesium, Potassium, And Sodium Oxybates | 5 | 40.1 | 40.2 |
| Elexacaftor, Tezacaftor, And Ivacaftor | 6 | 33.4 | 33.4 |
| Vedolizumab | 34 | 30.1 | 30.1 |
| Fremanezumab-Vfrm | 3 | 17.9 | 17.9 |
| Lifitegrast | 3 | 12.6 | 12.6 |